Monopar Therapeutics - MNPR

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
Aug 12, 2026 SCHEDULE 13G/A Saturn V Capital Management LP 4.7% 313,384 View
Aug 12, 2026 SCHEDULE 13G/A Xiaoying Tian 4.7% 313,384 View
Aug 12, 2026 SCHEDULE 13G/A Adage Capital Management, L.P. 4.76% 324,195 View
Aug 12, 2026 SCHEDULE 13G/A Robert Atchinson 4.76% 324,195 View
Aug 12, 2026 SCHEDULE 13G/A Phillip Gross 4.76% 324,195 View
May 15, 2026 SCHEDULE 13G Saturn V Capital Management LP 5.2% 345,626 View
May 15, 2026 SCHEDULE 13G Xiaoying Tian 5.2% 345,626 View
May 13, 2026 SCHEDULE 13G/A Adage Capital Management, L.P. 6.23% 424,195 View
May 13, 2026 SCHEDULE 13G/A Robert Atchinson 6.23% 424,195 View
May 13, 2026 SCHEDULE 13G/A Phillip Gross 6.23% 424,195 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.